Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus infection in dialysis: a continuing problem

B J Pereira1

  • 1Division of Nephrology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

Artificial Organs
|February 9, 1999
PubMed
Summary

Patients undergoing chronic dialysis face a high risk of hepatitis C virus (HCV) infection. Strategies to reduce HCV transmission and manage liver disease in these vulnerable patients are crucial.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of sirolimus alone or in combination with cyclosporine A on renal ischemia/reperfusion injury.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2010
Same author

Zinner's syndrome: an up-to-date review of the literature based on a clinical case.

Andrologia·2009
Same author

Effect of the Dialysis Membrane on Mortality of Chronic Hemodialysis Patients. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agadoa L. Kidney International 1996, 50:566-570.

Seminars in dialysis·2009
Same author

Management of chronic renal insufficiency: a call for a proactive approach.

Nephrology news & issues·2002
Same author

Trends in anemia at initiation of dialysis in the United States.

Kidney international·2001
Same author

Hemodialysis in acute renal failure: does the membrane matter?

Seminars in dialysis·2001

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Nephrology

Background:

  • Patients on chronic dialysis are susceptible to parenterally transmitted hepatitis viruses.
  • Hepatitis C virus (HCV) is a significant cause of liver disease in this population.
  • Biochemical liver function abnormalities affect 10-44% of hemodialysis patients.

Purpose of the Study:

  • To highlight the risk of hepatitis C virus (HCV) transmission in chronic dialysis patients.
  • To discuss the clinical course and consequences of HCV infection in this demographic.
  • To address the ongoing debate on strategies for reducing HCV transmission and managing liver disease.

Main Methods:

  • Review of existing literature on viral hepatitis in dialysis patients.
  • Analysis of the impact of hepatitis C virus (HCV) discovery on understanding non-A, non-B hepatitis.

Related Experiment Videos

  • Discussion of current strategies for HCV prevention and management in hemodialysis settings.

    • Main Results:

    • Hepatitis C virus (HCV) is now recognized as the primary cause of non-A, non-B hepatitis in dialysis patients.
    • Dialysis patients are at increased risk due to blood product transfusions and nosocomial transmission.
    • Effective strategies are needed to curb HCV spread and mitigate liver disease impact.

    Conclusions:

    • Reducing hepatitis C virus (HCV) transmission is a priority in hemodialysis units.
    • Management of liver disease in infected dialysis patients requires focused attention.
    • Further research and implementation of preventive measures are essential for patient well-being.